TheraLeaf signs letter of intent with Medipharm for pharmaceutical grade THC oils

Barcelona, Spain – May 7th, 2020

TheraLeaf has signed a Letter of Intent (LOI) with Medipharm, a licensed pharma grade producer of medical cannabis products to produce EU GMP pharma grade high THC oils for international distribution. TheraLeaf is excited to enter the next phase of its global expansion with distribution of pharma grade THC tinctures in the 25:1 (THC: CBD) and 10:10 (THC:CBD) varieties. In an official statement regarding the expansion of TheraLeaf’s medical cannabis product line, CEO Gabriel Shpilt says, “We are excited to be at the fore front of finished THC products and look forward to providing patients across Europe and Australiasia with a range of products that are efficacious, user friendly and safe in every sense of the word.”

Leave a Reply

Your email address will not be published. Required fields are marked *